Breaking News, Trials & Filings

Trials & Filings: Oct. 21, 2013

GSK, Genmab, Keryx, Iroko, Ganymed

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Filings GSK, Genmab submit sBLA for Arzerra in CLL… read more Keryx assigned PDUFA date for Zerenex… read more FDA approves Iroko’s Zorvolex… read more Ganymed’s IMAB362 receives Orphan Designation… read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters